Industry News


2026-01-20

How to determine whether the material of medical plastic packaging meets chemical stability requirements?

To assess the chemical stability of medical plastic packaging materials, it is necessary to combine standard testing methods with validation in real-world application scenarios. The core objective is to confirm that, throughout the entire lifecycle—from sterilization and storage to use—the material does not degrade, release harmful substances, or react with the packaged medical products. The specific approaches are as follows: Conduct compliance testing in accordance with national and international standards. Relevant tests shall be carried out in compliance with standards such as ISO 10993 (Biological evaluation of medical devices) and GB/T 16886, including: Extractables/Leachables Testing: Simulate sterilization and storage conditions to determine the levels of small-molecule substances leaching from the material into a simulated medium (e.g., water, ethanol), ensuring that the concentrations of these leachables remain within safe limits to prevent contamination of the packaged drugs or devices. Chemical Compatibility Testing: Directly contact the packaging with the packaged product, store under specified temperature and humidity conditions until the shelf life expires, and observe whether any chemical reactions occur, such as discoloration, swelling, cracking of the material, or changes in the product’s composition. Validation of Stability Under Simulated Sterilization Processes Different sterilization methods can affect the chemical stability of the material; therefore, post-sterilization performance testing is required: Steam Sterilization at High Temperatures: Test whether the material exhibits oxidative degradation or a reduction in molecular weight after repeated sterilization at 121°C or 134°C. Ethylene Oxide Sterilization: Determine the residual ethylene oxide and its derivatives in the material after sterilization, ensuring that their concentrations comply with the nationally prescribed safety limits. Gamma-Ray Sterilization: Verify whether the material generates toxic degradation products or experiences embrittlement, discoloration, or other adverse effects following irradiation. Long-Term Accelerated Aging Tests Conduct accelerated aging tests—such as increasing temperature and humidity—to simulate the storage conditions of the packaging during its shelf life and evaluate the material’s long-term stability: Analyze changes in the material’s chemical structure after aging using instruments such as infrared spectroscopy (IR) and differential scanning calorimetry (DSC). Assess whether the barrier properties and mechanical strength of the aged packaging have deteriorated, to prevent loss of the sterile barrier due to material degradation. Verification of Suitability for Clinical Application Scenarios Adjust test conditions according to the usage environment of the packaged product; for example: For reagent packaging used in low-temperature storage, test whether the material becomes brittle or releases substances under cold conditions. For packaging of implantable devices, conduct additional long-term in vivo simulation tests to confirm that any leachables from the material pose no risk of sensitization or mutagenicity.

2026-01-20

Why are medical plastic packaging regulations so stringent?

The stringent requirements for medical plastic packaging are centered on ensuring the safety and efficacy of medical products and protecting patient health, while also complying with industry regulatory standards. There are three key reasons for this: First, the need for a sterile barrier. Many medical devices and pharmaceuticals are supplied in a sterile condition, necessitating packaging with high barrier properties to prevent the ingress of moisture, oxygen, microorganisms, and other external contaminants, thereby safeguarding product integrity. For example, packaging for syringes and surgical blades must be completely sealed and puncture-resistant to avoid damage or microbial contamination during transportation and storage. Second, compatibility with sterilization processes. Most medical products undergo sterilization using methods such as steam at elevated temperatures or ethylene oxide; therefore, the packaging materials must withstand these conditions without releasing harmful substances and must maintain structural integrity. If the packaging fails to meet thermal resistance and chemical stability requirements, sterilization may be compromised, leading to product contamination. Third, compliance and traceability requirements. The medical industry is subject to rigorous oversight by regulatory authorities worldwide, and packaging must comply with standards such as ISO 11607, clearly labeling product information, sterilization date, expiration date, and other critical details to enable end-to-end traceability. In addition, packaging must exhibit robust mechanical strength to withstand stacking and handling during warehousing and logistics, thereby minimizing the risk of damage. In summary, the stringent standards governing medical plastic packaging serve as a critical link across the entire value chain—from manufacturing and sterilization to distribution and clinical use—and directly impact the safety of patient care.

2026-01-20

Does the choice of material for medical plastic packaging affect the product’s shelf life?

The selection of materials for medical plastic packaging directly affects the product’s shelf life, with the key determinants being the material’s sterile barrier performance and chemical stability. These two properties dictate whether a medical product can maintain a sterile and stable condition throughout its specified shelf life. Barrier Performance Determines Sterile Shelf Life The primary prerequisite for the shelf life of medical products is that the packaging continuously prevents the ingress of external microorganisms, moisture, and oxygen. Significant differences exist in the barrier properties among various materials: Polyamide (PA) and polyester (PET) exhibit excellent barrier properties, effectively blocking gases and moisture over long periods; when combined with polyethylene (PE) to form composite films, they can substantially extend the shelf life of implantable devices and high-end pharmaceuticals. Low-density polyethylene (LDPE), by contrast, has relatively poor barrier properties and is suitable only for packaging ordinary consumables with shorter shelf lives. If the material’s barrier performance is inadequate, external contaminants will gradually penetrate, leading to premature deactivation or contamination of the product and necessitating a reduction in its shelf life. Chemical Stability Prevents Product Deterioration If the material degrades during sterilization or storage, or if it releases small-molecule substances, these may react with the packaged product, accelerating its deterioration. Polypropylene (PP) boasts strong chemical stability, withstands high-temperature steam sterilization, and is unlikely to leach harmful substances, thereby ensuring the long-term stability of products such as infusion sets and syringes. In contrast, certain low-quality plastic materials may contaminate drugs or medical devices through additive migration, directly shortening the product’s shelf life and even posing safety risks. Age Resistance Meets Long-Term Storage Requirements The material’s resistance to aging and to fluctuations in temperature and humidity also impacts shelf life. For example, polycarbonate (PC) exhibits excellent weather resistance and is well suited for packaging reusable, sterilizable devices that require long-term storage; by contrast, conventional polyethylene (PE) tends to age and become brittle under intense light and high temperatures, making it unsuitable for meeting the demands of long-shelf-life storage.

2026-01-20

How to Choose the Packaging for Eye Drop Bottles

The selection of eye-drop bottle packaging must center on three core requirements: stability of the drug solution, sterility assurance, and ease of use, while also ensuring medical compliance and patient safety. Specific considerations are as follows: Prioritize materials that are compatible with the characteristics of the drug solution. Since eye-drop bottles come into direct contact with the drug solution, the material must exhibit high chemical stability—no reaction with the solution and no leaching of harmful substances. Commonly used medical-grade materials include: Low-density polyethylene (LDPE): Soft and easy to squeeze, moderately priced, and chemically stable; suitable for most aqueous eye drops such as artificial tears and antibiotic eye drops. However, its barrier properties are relatively weak, making it unsuitable for oxidizable formulations. High-density polyethylene (HDPE): Harder and more puncture-resistant, with superior barrier properties compared with LDPE; ideal for preservative-containing eye drops or formulations requiring long-term storage. Polypropylene (PP): Excellent temperature resistance, capable of withstanding steam sterilization, and highly chemically inert; suitable for specialized eye drops containing acidic or alkaline ingredients or those prone to hydrolysis. It can also be manufactured into rigid, graduated bottles for precise dose control. Polyester (PET): Outstanding barrier properties, effectively blocking oxygen and moisture; well-suited for oxidizable eye drops such as vitamin-based and hormone-based formulations. Often produced in single-use, small-volume vials (1–2 mL) to minimize contamination from repeated use. Contraindication: Avoid using polyvinyl chloride (PVC), as its plasticizers may migrate into the drug solution and cause ocular irritation. Strengthen the sterile barrier and anti-contamination design. Given the fragility of the ocular mucosa, eye drops must remain sterile throughout their entire lifecycle, so the packaging design must meet the following requirements: Sealing structure: Employ a double-seal system consisting of a screw cap and an inner stopper. The inner stopper should preferably be made of medical-grade silicone, offering excellent sealing performance and good compatibility with the drug solution to prevent leakage or microbial ingress during transport. Single-use vs. multi-use: Preservative-free eye drops should be packaged in single-use, small-volume containers (daily-disposable type) and used immediately after opening; preservative-containing eye drops may be offered in larger-volume bottles, but the post-opening shelf life must be clearly labeled (typically no more than 4 weeks). Sterilization compatibility: The packaging material must withstand ethylene oxide or gamma-ray sterilization without leaving toxic residues, thereby ensuring the sterility of the drug solution inside the bottle. Balance convenience and safety in use. The packaging design should align with patients’ habitual usage patterns to reduce operational risks: Bottle design: Rigid bottles should have a non-slip surface, while flexible bottles should be easy to squeeze and possess good resilience to prevent over-dosing due to excessive force; the bottle mouth should be smooth and rounded to avoid scratching the eyelid. Light protection: For photosensitive drugs such as B vitamins and levofloxacin, brown or opaque materials should be selected, or the bottle should be paired with a light-protective outer box to prevent photodegradation and loss of efficacy. Clear labeling: The bottle must clearly display information such as the drug name, concentration, expiration date, post-opening shelf life, and storage conditions, with legible, easy-to-read fonts. Compliance with medical packaging standards. The packaging must comply with the Chinese Pharmacopoeia and the YBB series standards for pharmaceutical packaging materials, pass biocompatibility testing (no sensitization or irritation), and meet the registration requirements of the National Medical Products Administration, ensuring that both the materials and design adhere to medical-grade specifications.

< 12 >